ArticleFrontiers in immunology2025

Case Report: Camrelizumab plus gemcitabine followed by concurrent chemoradiation for HPV-positive and PD-L1-positive tonsillar squamous cell carcinoma.

Xuesong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.